Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Liver Neoplasms 1Gallbladder Neoplasms 1Fatigue 1Esophageal Neoplasms 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Bile Duct Neoplasms 1Behavior, Addictive 1

Interventions

Fluorouracil 17Cisplatin 17pembrolizumab 12Radiotherapy 11Oxaliplatin 10Irinotecan 9Paclitaxel 6Leucovorin 6Docetaxel 6Carboplatin 6Capecitabine 6Neoadjuvant Therapy 5Trastuzumab 4Panitumumab 4Gefitinib 4Esophagectomy 4Cyclophosphamide 4Cetuximab 4Surgical Procedures, Operative 3Celecoxib 3tegafur-gimeracil-oteracil 2spartalizumab 2sodium glycididazole 2niraparib 2fludarabine 2S 1 (combination) 2Plicamycin 2Pemetrexed 2Lapatinib 2Gemcitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Esophageal Neoplasms × Escitalopram × Clear all
NCT00387348 2012-12-03

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Massachusetts General Hospital

Phase 3 Terminated
24 enrolled 11 charts
GastrointestinalThoracic

Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Depression, Esophageal Neoplasms, Fatigue, Gallbladder Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡